Basic Information
ID: ALA5040287
Type: Binding
Description: Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate at 0.09 uM by NanoLuc luciferase assay
Format: BAO_0000219
Organism: Homo sapiens
Cell type: HEK293T
Target: Angiotensin-converting enzyme 2(ALA3736)
Document: ALA5038603
Inhibition of SARS-COV2 S-RBD binding to human ACE2 expressed in HEK293T cells using FMZ as substrate at 0.09 uM by NanoLuc luciferase assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5040287
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 2897.20 | ||
| 1752.94 | ||
| 2778.93 | ||
| 1993.04 |